EUVIMEDEUVIMED entdecken
Open Access

Cell Selective STING‐Activating Polysaccharide Immunomodulators for Cancer Therapy

Qianli Zhu, Jiaqian Miao, Danni Xu, Minxia Zhang, Sisi Chen, Junjie Wang, Weiyi Chen, Jiaxuan Guo, Li Xu, Sheng Ma iD, Guangbo Ge, Xinyuan Zhu und 1 weitere

Advanced Materials · 2026-08 · 38 (48)

DOI: 10.1002/adma.74178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.07.2026. Verfasst von Qianli Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center of TCM …. Hauptthemen laut MEDLINE: Membrane Proteins, Polysaccharides, Immunologic Factors, Immunomodulating Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, State Key Laboratory of Polymer Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of the stimulator of interferon genes (STING) signaling pathway represents a robust strategy to reverse tumor immunosuppressive microenvironment (TIME) for cancer therapy. However, selective STING activation and its quantitative comparison across heterogeneous cell populations remain a tremendous challenge. Herein, we engineered a type of selective STING‐activating polysaccharide immunomodulators (SSAPIs) with quantitative STING activation efficiency across tumor cell, macrophage, and dendritic cell (DC). Dextran as an immune cell targeting nanocarrier was employed to improve drug delivery to macrophage and DC, and to avoid the impact of macromolecular self‐assembly on drug release kinetics. The STING agonist (DMXAA) was conjugated to dextran via defined linkers to control the selectivity of STING activation in different cell populations. In vitro experiments quantitively revealed the enhanced STING activation of the ester linker SSAPI (DESX) in macrophage, while the disulfide linker SSAPI (DSSX) prompted STING activation across tumor cell and immune cell. In B16F10 and CT26 tumor‐bearing mice models, DSSX exhibited much superior antitumor efficacy with six out of eight complete tumor remission by inducing broad immune responses across diverse cell populations to reprogram TIME. Collectively, this work highlights the significance of activating the STING signaling pathway across cell populations in solid tumor for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsPolysaccharidesImmunologic FactorsImmunomodulating AgentsNeoplasmsAntineoplastic AgentsAnimalsSTING ProteinMiceMacrophagesHumanscGAS-STING Signaling PathwayCell Line, TumorDendritic CellsDextransSignal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

STINGbiomedical polymersdrug deliveryimmunotherapypolysaccharide

Substanzen

STING ProteinMembrane ProteinsPolysaccharidesImmunologic FactorsSting1 protein, mouseDextransImmunomodulating AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine…
  • State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China.
  • School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Sheng Ma, Hongping Deng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • State Key Laboratory of Polymer Science and Technology
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Zhu, Q., Miao, J., Xu, D., Zhang, M., Chen, S., Wang, J., Chen, W., Guo, J., Xu, L., Ma, S., Ge, G., Zhu, X., & Deng, H. (2026). Cell Selective STING‐Activating Polysaccharide Immunomodulators for Cancer Therapy. Advanced Materials, 38(48). https://doi.org/10.1002/adma.74178

Vancouver

Zhu Q, Miao J, Xu D, Zhang M, Chen S, Wang J, et al. Cell Selective STING‐Activating Polysaccharide Immunomodulators for Cancer Therapy. Advanced Materials. 2026;38(48). doi:10.1002/adma.74178

BibTeX
@article{Zhu2026,
  author = {Zhu, Qianli and Miao, Jiaqian and Xu, Danni and Zhang, Minxia and Chen, Sisi and Wang, Junjie and Chen, Weiyi and Guo, Jiaxuan and Xu, Li and Ma, Sheng and Ge, Guangbo and Zhu, Xinyuan and Deng, Hongping},
  title = {Cell Selective STING‐Activating Polysaccharide Immunomodulators for Cancer Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {48},
  doi = {10.1002/adma.74178}
}
Kostenlos starten →